NEXT

New Jersey Law Journal

Mezzion Pharma Will Have to Turn Over Udenafil Manufacturing Process Information in Discovery Dispute

"In a ruling from the bench, Judge Hurd concluded that 'at the end of the day it's not a question of admissibility, it's a question of is it reasonably calculated to lead to the discovery of admissible evidence under Rule 4:10- 2," the opinion said.
4 minute read

New York Law Journal

In $270M National Settlement, Generic Opioid Maker Will Supply Overdose Reversal Pill, Cash

The settlement in principle accounts for New Jersey-based Amneal's role in fueling the national epidemic of opioid addictions and overdoses, New York and California said in separate statements.
3 minute read

Corporate Counsel

Founding GC of Animal Health Giant Zoetis Steps Down

Heidi Chen spent 13 years at Pfizer before she helped spin out the company's animal-health business into a stand-alone public company in 2012 and became its first legal chief.
2 minute read

New Jersey Law Journal

'Like You're Eating Cyanide': Litigation Over 'Gas Station Heroin'

"It's called an unapproved drug. It's a drug in other countries, this tianeptine, used for an antidepressant. But it's never been approved in America, and I think it's falling through the regulatory cracks," plaintiff attorney Michael Pender said.
4 minute read

The Legal Intelligencer

Ozempic Leadership Fight Escalates: Proposed Co-Leads Are 'Losing Control'

Sarah Foster, of Schlesinger Law Offices in Fort Lauderdale, continued to insist she and others were excluded from the Ozempic leadership process, noting the last-minute addition of two lawyers to the proposed team.
6 minute read

National Law Journal

Massachusetts Court: 'Real Time' Clinical Trial Data Not Needed to Avoid Securities Claims

U.S. District Judge Angel Kelley wrote that Latham & Watkins-repped Homology Medicines Inc. "had no duty to disclose data in real time."
2 minute read

The Legal Intelligencer

Under Fire, Ozempic Lawyers Add Two 'Team Players' to Proposed Leadership

Plaintiffs lawyers who assembled a proposed leadership team in Ozempic lawsuits fired back at the accusation that they excluded attorneys—then added two more lawyers to their proposed team.
5 minute read

Law.com

Despite Call for Civility, 'Squabbles Among Counsel' Emerge Over Ozempic Leadership

Plaintiffs lawyers in the Ozempic multidistrict litigation organized a leadership team of 30 attorneys, but one Florida attorney objected to the proposed slate, which she says appears to be composed of 'repeat players.'
5 minute read

The Legal Intelligencer

'How Can It Be Enough?': Thousands Have Agreed to the Risperdal Settlement. A Few Holdouts Remain

According to attorneys leading the litigation, more than 5,600 have agreed to the settlement, which is about 94% of the potential 6,000 claims for the bulk settlement. The lawyers said 99.9% of claimants have chosen to accept their settlement offers.
12 minute read

New Jersey Law Journal

McCarter & English File Patent Infringement Suit on Behalf of Merck, Others Over Migraine Medication Ubrelvy

This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide.
3 minute read

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now